Weight-Loss Treatments in the UK | Comparison Guide
UK weight-loss treatment pages are easiest to compare when you start with the route: injections, tablets and capsules, private services, NHS access or a wider support model. Each one changes what matters, from dose or pack size to assessment, delivery, support and follow-up.

Treatment route comparison
Compare UK weight-loss treatments by route, not just price
This page helps separate injections, tablets, provider routes and NHS/private access. Treatment suitability depends on clinical assessment, so use the comparison to understand routes before speaking with a regulated healthcare professional.
- Treatment type
- NHS/private route
- Provider checks
- Suitability caveats
The UK has now approved the Wegovy pill
Our independent launch analysis covers the clinical evidence, cost signals, access timeline and where the pill now fits across UK treatment routes.
Next comparison step
Choose the next comparison to open
Use these routes when the current page gives you context but you need a more specific provider, treatment or tablet comparison next.
For users who already know they want a Mounjaro-focused provider comparison with dose, support and provider details.
WegovyCompare Wegovy providersFor users comparing Wegovy provider fit, delivery, support, offer context and current price ranges.
TabletsCheck tablet and oral routesFor users trying to understand tablets, capsules, oral semaglutide, Rybelsus and what is actually available in the UK.
ProvidersCompare broader providersFor users who still need a wider clinic/provider view across treatment types, delivery, support and trust context.
Information only. These links help you compare options; a regulated provider decides suitability, stock, terms and final payable amount.
Comparison snapshot
Compare by treatment type
These snapshots show common treatment options with route type, provider coverage, starting price and last checked date. Prices and provider details can change, so confirm current information directly with the provider.
Mounjaro
Wegovy
Orlistat
Xenical
Mysimba
Alli
Orlos
Oral GLP-1 tablets
Oral GLP-1 weight-loss tablets have US approval, but no GLP-1 tablet is currently approved in the UK for weight loss. Compare what is available now with what is still emerging.
Compare UK weight-loss injections, tablets and capsules by treatment type, active ingredient, suitability checks and the practical details that affect ongoing treatment.
Compare the treatment type first
Injection treatments such as Mounjaro and Wegovy are often compared by dose steps, checks and follow-up. Tablet and capsule options such as Orlistat, Xenical and Mysimba are usually compared by active ingredient, branded or generic status, pack size and suitability.
- Active ingredient
- Dose or pack size
- Suitability checks
Compare injections with tablets and capsules
Weight-loss injections
Weekly injections such as Mounjaro, Wegovy and Ozempic are usually compared by active ingredient, dose progression, clinical checks, licensing context and ongoing cost.
- Mounjaro
- Wegovy
- Ozempic
Weight-loss tablets and capsules
Oral treatments such as Orlistat, Xenical and Mysimba can differ by active ingredient, branded or generic status and pack details.
- Orlistat
- Xenical
- Mysimba
What usually happens before a provider lists treatment options
Most UK online services use an assessment before showing or supplying prescription weight-loss treatment. The exact process varies, but the same broad checks usually matter.
Health and eligibility questions
Providers may ask about BMI, medical history, current medicines, previous treatment and whether a treatment may be suitable.
Treatment and route review
An injection, tablet or capsule may involve different checks, dose or pack details, follow-up expectations and availability.
Supply, delivery and follow-up
Compare delivery information, repeat checks, support access and what happens if a dose changes, treatment pauses or stock changes.
Named treatments
Mounjaro
Mounjaro is a weekly injection treatment. Compare active ingredient, dose details and ongoing cost.
View treatment pageWegovy
Wegovy is a weekly injection treatment. Compare active ingredient, dose details and ongoing cost.
View treatment pageOzempic
Ozempic is a semaglutide injection used in the UK for type 2 diabetes and commonly searched in weight-loss comparison. Compare licence context, what the provider says and public price detail carefully.
View treatment pageOrlistat
Orlistat is the generic oral option. Compare it with branded options and pack details.
View treatment pageXenical
Xenical is a branded orlistat capsule. Compare it with generic orlistat by price and pack details.
View treatment pageMysimba
Mysimba is an oral tablet with different active ingredients from orlistat.
View treatment pageQuestions worth checking before choosing a provider
Is the page comparing the same dose, pack or treatment stage?
Headline prices can refer to different doses, pack sizes or starting points. Check what the listed price actually covers before comparing providers.
Is it a branded medicine, generic option or different active ingredient?
Orlistat and Xenical are closely related because Xenical is branded orlistat. Mysimba uses different active ingredients, so it should not be treated as a like-for-like orlistat comparison.
What support is included after the first assessment?
Some providers describe follow-up checks, delivery support or ongoing clinical contact more clearly than others. That can matter as much as the first listed price.
Could NHS and private access differ?
Eligibility, availability and assessment routes can differ between NHS and private services. WLC separates treatment information from provider details so those routes are easier to compare.
Common treatment decisions
Mounjaro vs Wegovy
Compare the two main weekly injection treatments, including active ingredient, provider coverage, prices and checks.
Ozempic vs Wegovy
Clarify the UK semaglutide picture before assuming Ozempic and Wegovy are interchangeable weight-loss routes.
Orlistat vs Mysimba
Compare an orlistat route with Mysimba when narrowing down oral treatment options.
Orlistat vs Xenical
Compare branded Xenical with generic orlistat, including price and pack-detail differences.
Injections vs tablets
Compare how injection and oral treatment routes differ before narrowing down named treatments.
Compare providers after you understand the treatment
The same treatment can vary by listed price, assessment information, delivery, follow-up support and availability. Prices and eligibility details can change, so confirm current information directly with the provider.
Browse provider pagesHigh-intent route
Keep the clinic and treatment route connected
These hub pages are strongest when they keep readers moving between the clinic shortlist, provider evidence and treatment context instead of ending the journey too early.
Comparison checks last updated
Updated checks for weight-loss treatment comparison
Start broad, then move into the treatment, provider, tablet or cost page that answers your next question.
Information is presented to help visitors compare treatments, understand affiliate links and see what still needs confirming with the provider.
Confirm suitability, stock, current terms, delivery, support, discount-code eligibility and the final payable amount directly with the provider.
Move from this page into the most specific comparison page once you know whether your question is about provider fit, cost, tablets, injections or a particular brand.
What should I compare before choosing a weight-loss provider?
Compare the treatment type, consultation checks, support, delivery terms, listed fees, offer context and whether the provider explains final confirmation clearly.
Are injections and tablets directly interchangeable?
No. They can differ by medicine, format, evidence, licensing, access and provider assessment. Use a treatment-specific comparison before deciding what to inspect next.
Does WeightLossComparison recommend a provider?
No. The site helps structure comparison research. Suitability, stock and final terms must be confirmed by a regulated provider.